A new manuscript from the IGNITE Pragmatic Trials Network has been published in JAMA Network Open, describing the primary results of the GUARDD-US study. GUARDD-US is a randomized controlled trial examining the impact of returning APOL1 genetic risk results to ...
|
Sunday
|
Monday
|
Tuesday
|
Wednesday
|
Thursday
|
Friday
|
Saturday
|
|---|---|---|---|---|---|---|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
0 events,
|
|
0 events,
|
1 event,
-
PTEN hamartoma tumor syndrome: A personalized healthcare journey Monday, August 22 | 12-1 p.m. ET | Virtual Charis Eng, MD, PhD, FACP, is a leader in the field of cancer genetics. She was the first to discover a link between mutations in the cancer suppressor gene PTEN and Cowden syndrome and other disorders that can […] |
0 events,
|
0 events,
|
1 event,
-
CDC Webinar - The Routine Failure to Clinically Identify Monogenic Cases of Common Disease in Clinical Practice: Addressing Diagnostic Misattributions and Errors Thursday, August 25 | 11 a.m. - 12 p.m. ET | Virtual Changes in clinical and laboratory practice are needed to improve the diagnosis of monogenic forms of common diseases. This webinar seeks […] |
0 events,
|
0 events,
|
|
0 events,
|
0 events,
|
0 events,
|
1 event,Genomic Medicine XIV: Genomic Learning Healthcare Systems Wednesday, August 31 – Thursday, September 1, 2022 | 11 a.m. - 5 p.m. ET | Virtual On August 31 - September 1, 2022, the National Human Genome Research Institute (NHGRI) will sponsor its 14th Genomic Medicine meeting, Genomic Medicine XIV: Genomic Learning Healthcare Systems. This meeting will […] |
0 events,
|
0 events,
|
GMKB